Health and Healthcare

What to Expect When Johnson & Johnson Reports Tuesday

Wikimedia Commons

Johnson & Johnson (NYSE: JNJ) is scheduled to report its third-quarter financial results before the markets open on Tuesday. The consensus estimates are calling for $2.03 in earnings per share (EPS) and $20.05 billion in revenue. The same period of last year reportedly had $1.90 in EPS and $19.65 billion in revenue.

The firm’s strong second-quarter results reflected double-digit growth in its Pharmaceutical business and the accelerating sales momentum in its Medical Devices business, driven by the continued growth of its market-leading products and strategic new launches.

Alex Gorsky, board chair and chief executive, commented in the second quarter:

We remain focused on investing in innovation and meeting the needs of our customers by delivering innovative products and solutions that position the company to deliver long-term, sustainable growth. Our talented J&J colleagues are united in our efforts to address some of the most critical health and consumer needs of people around the world.

Also at that time, Johnson & Johnson updated its full-year guidance. The company now expects to see EPS in the range of $8.07 to $8.17 and revenues between $80.5 billion and $81.3 billion. The consensus estimates now are $8.15 in EPS and revenue of $81.23 billion for the year.

Overall, Johnson & Johnson has underperformed the broad markets, with the stock down 2% in the past 52 weeks. In just 2018 alone, the stock is down 4%.

A few analysts weighed in on Johnson & Johnson ahead of the report:

  • Credit Suisse has a Buy rating with a $149 price target.
  • Wells Fargo has an Outperform rating and a $160 target.
  • Jefferies has a Buy rating with a $145 price target.
  • Goldman Sachs has a Neutral rating.

Johnson & Johnson shares were last seen trading at $133.95, with a consensus analyst price target of $144.32 and a 52-week trading range of $118.62 to $148.32.

Are You Still Paying With a Debit Card?

The average American spends $17,274 on debit cards a year, and it’s a HUGE mistake. First, debit cards don’t have the same fraud protections as credit cards. Once your money is gone, it’s gone. But more importantly you can actually get something back from this spending every time you swipe.

Issuers are handing out wild bonuses right now. With some you can earn up to 5% back on every purchase. That’s like getting a 5% discount on everything you buy!

Our top pick is kind of hard to imagine. Not only does it pay up to 5% back, it also includes a $200 cash back reward in the first six months, a 0% intro APR, and…. $0 annual fee. It’s quite literally free money for any one that uses a card regularly. Click here to learn more!

 

Flywheel Publishing has partnered with CardRatings to provide coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.